UBS Group’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-68,425
| Closed | -$3.13M | – | 7316 |
|
|
2017
Q4 | $3.13M | Sell |
68,425
-59,355
| -46% | -$2.71M | ﹤0.01% | 2199 |
|
|
2017
Q3 | $5.73M | Sell |
127,780
-39,916
| -24% | -$1.79M | ﹤0.01% | 1642 |
|
|
2017
Q2 | $5.01M | Buy |
167,696
+98,683
| +143% | +$2.95M | ﹤0.01% | 1693 |
|
|
2017
Q1 | $1.53M | Sell |
69,013
-119,011
| -63% | -$2.64M | ﹤0.01% | 2531 |
|
|
2016
Q4 | $3.54M | Buy |
188,024
+30,452
| +19% | +$574K | ﹤0.01% | 1840 |
|
|
2016
Q3 | $4.73M | Buy |
157,572
+66,851
| +74% | +$2.01M | ﹤0.01% | 1581 |
|
|
2016
Q2 | $3.49M | Buy |
90,721
+52,957
| +140% | +$2.04M | ﹤0.01% | 1798 |
|
|
2016
Q1 | $1.44M | Sell |
37,764
-95,515
| -72% | -$3.64M | ﹤0.01% | 2392 |
|
|
2015
Q4 | $5.86M | Buy |
133,279
+49,439
| +59% | +$2.17M | ﹤0.01% | 1412 |
|
|
2015
Q3 | $3.41M | Buy |
83,840
+73,668
| +724% | +$3M | ﹤0.01% | 1760 |
|
|
2015
Q2 | $543K | Sell |
10,172
-124,511
| -92% | -$6.65M | ﹤0.01% | 3209 |
|
|
2015
Q1 | $8.17M | Buy |
134,683
+38,071
| +39% | +$2.31M | 0.01% | 1281 |
|
|
2014
Q4 | $5.05M | Buy |
+96,612
| New | +$5.05M | ﹤0.01% | 1600 |
|